Alkali Metals Limited Schedules Board Meeting on May 26, 2026 to Approve Q4 and FY26 Audited Financial Results
Alkali Metals Limited has intimated stock exchanges of a Board of Directors meeting scheduled for May 26, 2026, to be held via two-way audio-visual means under Regulation 29 of SEBI (LODR) Regulations, 2015. The board will consider and approve audited financial results for the fourth quarter and financial year ended March 31, 2026. Additionally, the board will deliberate on the recommendation of a dividend, if any, along with other business matters. The intimation was filed on May 18, 2026, by Company Secretary & Compliance Officer Siddharth Dubey.

*this image is generated using AI for illustrative purposes only.
Alkali Metals Limited has notified the stock exchanges of a forthcoming Board of Directors meeting, scheduled for Tuesday, May 26, 2026. The meeting will be conducted through two-way audio-visual means, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed on May 18, 2026, and signed by Siddharth Dubey, Company Secretary & Compliance Officer.
Board Meeting Details
The following key agenda items have been disclosed for the upcoming board meeting:
| Parameter: | Details |
|---|---|
| Meeting Date: | Tuesday, May 26, 2026 |
| Mode: | Two-way audio-visual means |
| Regulatory Basis: | Regulation 29, SEBI (LODR) Regulations, 2015 |
| Financial Period Under Review: | Fourth Quarter and Financial Year ended March 31, 2026 |
| Key Agenda Items: | Approval of Audited Financial Results, Dividend recommendation (if any), Other business items |
Agenda Overview
The primary purpose of the meeting is to consider and approve the audited financial results of the company for the fourth quarter and the full financial year ended on March 31, 2026. In addition to the financial results, the board will also deliberate on the recommendation of a dividend, if any, for the relevant period. Other business items are also listed on the agenda, though further details have not been disclosed in the intimation.
About Alkali Metals Limited
Alkali Metals Limited is headquartered at Plot B-5, Block III, IDA, Uppal, Hyderabad – 500 039, India. The company is engaged in the manufacture of a range of specialty chemicals and pharmaceutical intermediates, including:
- Sodium Amide
- Sodium Alkoxides
- Sodium Hydride
- Sodium Azide
- Tetrazoles
- Amino Pyridines
- Pyridine Derivatives
- Cyclic Compounds
- Fine Chemicals
- Intermediates for pharmaceuticals
- Active Pharmaceutical Ingredients
The company holds ISO 9001 & 14001 certifications and operates under CIN: L27109TG1968PLC001196.
Historical Stock Returns for Alkali Metals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.96% | +29.53% | +30.42% | +4.38% | -14.32% | +44.68% |
How might Alkali Metals Limited's FY2026 financial results compare to industry peers in the specialty chemicals and pharmaceutical intermediates sector?
What factors could influence the board's decision on dividend recommendation, given current market conditions and the company's capital expenditure plans?
Could the approval of FY2026 audited results trigger any strategic announcements, such as capacity expansions or new product launches in the pharmaceutical intermediates space?































